Halozyme Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
CEOHelen I. Torley
CEOHelen I. Torley
Employees350
Employees350
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1998
Founded1998
Employees350
Employees350
HALO Key Statistics
Market cap7.68B
Market cap7.68B
Price-Earnings ratio14.63
Price-Earnings ratio14.63
Dividend yield—
Dividend yield—
Average volume2.47M
Average volume2.47M
High today$66.00
High today$66.00
Low today$64.42
Low today$64.42
Open price$64.80
Open price$64.80
Volume871.21K
Volume871.21K
52 Week high$70.51
52 Week high$70.51
52 Week low$42.01
52 Week low$42.01
HALO News
Investing.com 20h
Halozyme’s CEO Helen Torley sells $3.8m in shares - Investing.com...
Analyst ratings
60%
of 10 ratingsBuy
60%
Hold
30%
Sell
10%
People also own
Based on the portfolios of people who own HALO. This list is generated using Robinhood data, and it’s not a recommendation.